Nanotechnology has the potential to revolutionize medical treatments and medical practice. With hundreds of nanodrugs in development globally, the opportunities for clinical and market successes are apparent. Nanodrugs are at the forefront of bioengineering for diseases such as cancer, cardiovascular disease, and age-related conditions and represent the next generation of medical therapies that will impact worldwide markets, healthcare, and industry.

Arrowhead–Spectra’s 1st International Conference on Nanodrugs and Clinical Nanotechnology provides an unmissable forum to learn the challenges and advances of pioneers in nanodrug development and the nanotechnologies applied to medical therapies. Case studies of pipelines, progress and clinical efficacy, and challenges of bioengineering and manufacturing will be the main themes of the conference.

We invite both companies and academia to send us abstracts for product- or market-related presentations that we will considered for the event.